Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Inahled Isoflurane

Phase 3Small molecule

AAssistance Publique - Hôpitaux de Paris

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Timeline

Expected Milestones

Q2 2029

Phase 3Not yet recruiting

Sedation

NCT07099014

Clinical

Trials by Indication[1]

Sedation1 trial

Inhaled Isoflurane for Sedation of Invasively Ventilated Patients With Cardiogenic Shock on Extracorporeal Membrane Oxygenation

Not yet recruiting·AAssistance Publique - Hôpitaux de Paris·Phase 3·NCT07099014·300 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Inahled Isoflurane. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Inahled Isoflurane compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Inahled Isoflurane. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Assistance Publique - Hôpitaux de Paris company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: AAssistance Publique - Hôpitaux de Paris

Related News